MMS Holdings Expert Insights Blog
Experts at MMS share their insights on trending
topics in the pharmaceutical industry.
FDA Orphan Drug Designation Applications Whitepaper
[Fill out the form below to access the whitepaper] The Orphan Drug Act, established in 1983, provides incentives to sponsors for promoting the development of drugs for the prevention, diagnoses, and treatment of rare diseases or conditions that affect fewer than...
MMS Academy Partners with MPGI in India
Uttar Pradesh, India (August 18, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused and technology-enabled CRO – announced today that Maharana Pratap Group of Institutions (MPGI) has partnered with MMS Academy, the learning arm of MMS. In the...
MMS Wins Award for Most Innovative Clinical Research Organization
CANTON, Mich. (July 20, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that it has been recognized by Corporate LiveWire as the Most Innovative Clinical Research Organization (CRO) in the United States. As part of their Innovation...
Why COVID-19 testing devices require a high level of specificity
Note: To use the dashboard, read the article below, then click the arrows on the dashboard to enter full screen mode. Use the dashboard to find the prevalence of COVID-19 among tested individuals within your region of interest. Then, adjust the sensitivity,...
Whitepaper: Pharmaceutical Industry Challenges Facing Clinical Trial Disclosure and Transparency
By MMS Holdings and TrialAssure [Fill out the form below to access the whitepaper] While global regulatory authorities routinely update clinical trial disclosure and transparency requirements, new regulations set to take effect in 2020 and 2021 will dramatically...
Helping to Accelerate the Search for Solutions to the COVID-19 Crisis
The full article can be read on the IBM Watson Health website. An excerpt of the article is below. The novel coronavirus (COVID-19) pandemic is an unprecedented crisis that has galvanized the global scientific community around the search for a viable vaccine and...
IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment
THUNDER BAY, ONTARIO (June 09, 2020) — IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the development of IgY-110, an anti-CoV-2 therapeutic antibody with a focus on a nasal spray...
University of Michigan School of Information Invites MMS Holdings Executive Kelly J. Hill to Join External Advisory Board
CANTON, Mich. (May 19, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that its Executive Director of Global Business Operations and Strategy Kelly J. Hill has accepted an invitation to join the University of Michigan School of...
On Demand Webinar: Recommended Changes for Pharma Companies in Response to COVID-19
[Fill out the form below to register] In the wake of the COVID-19 pandemic, governments across the globe have rushed to implement countermeasures and develop best practices to curtail the spread of the virus, impacting the conduct of clinical trials in unprecedented...